FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

40203011000001108: Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2071981000001111 Ontozry 150mg tablets (Arvelle Therapeutics UK) 14 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2071991000001113 Ontozry 150mg tablets (Arvelle Therapeutics UK) 14 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2196181000001116 Ontozry 150mg tablets (Angelini Pharma UK-I Limited) 14 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2196191000001119 Ontozry 150mg tablets (Angelini Pharma UK-I Limited) 14 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2504051000001110 Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2504061000001113 Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has AMP Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Is a Cenobamate 150mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has specific active ingredient Cenobamate true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start